Franchi Dorella, Boveri Sara, Radice Davide, Portuesi Rosalba, Zanagnolo Vanna, Colombo Nicoletta, Testa Antonia Carla
Division of Gynecology, European Institute of Oncology, Milan, Italy.
Division of Gynecology, European Institute of Oncology, Milan, Italy.
Am J Obstet Gynecol. 2016 Dec;215(6):756.e1-756.e9. doi: 10.1016/j.ajog.2016.07.024. Epub 2016 Jul 18.
Borderline ovarian tumors are generally diagnosed in young women. Because of the young age of patients at first diagnosis and at recurrence, and given the good prognosis of borderline ovarian tumors, a conservative surgical approach in those women who wish to preserve their fertility is advised. In this scenario, transvaginal ultrasound examination plays a key role in the detection of borderline ovarian tumor recurrence, and in assessment of amount of normal functioning parenchyma remaining. To date, no data are available about the natural history of borderline ovarian tumor recurrence.
The aim of the study was to determine growth rate of recurrent ovarian cysts by a scheduled follow-up by ultrasound examination, in women previously treated with fertility-sparing surgery due to borderline ovarian tumors.
In this prospective observational study, we collected data from 34 patients previously treated with fertility-sparing surgery due to borderline ovarian tumors, who had a suspicious recurrent lesion. The patients underwent transvaginal ultrasonographic examination every 3 months, until the clinical setting recommended proceeding with surgery. According to cyst size at study entry, they were categorized into 3 groups: ≤10 mm, 10-20 mm, and >20 mm. Summary statistics for cyst size, growth rate, and the probability of remaining within the same dimension category at first ultrasound during the follow-up were also obtained. For each cyst the growth rate was calculated as the slope of the linear interpolation between 2 consecutive measurements.
Follow-up timing (P < .001), cyst size (P < .001), and micropapillary pattern (P < .001) were factors significantly affecting the cyst growth both in univariate and multivariate analysis. According to size category at first ultrasound, growth rate ranges from a minimum of 0.06 mm/mo for cysts <10 mm up to 1.92 mm/mo for cysts >20 mm. The final histology of all recurrent lesions confirmed the same histotype of primary borderline ovarian tumors.
This article represents the first observational study that describes the trend in the growth rate of borderline ovarian tumor recurrence in relation to their size detected at the first ultrasound examination. The findings of this study seem to confirm, in selected patients, that a thorough ultrasonographic follow-up of borderline ovarian tumor recurrence has proven to be safe and feasible. The final goal of such management is to maximize the impact on fertility potential of these young women without worsening their prognosis.
卵巢交界性肿瘤通常在年轻女性中被诊断出来。鉴于患者初次诊断及复发时年龄较轻,且卵巢交界性肿瘤预后良好,对于那些希望保留生育能力的女性,建议采取保守性手术方法。在这种情况下,经阴道超声检查在检测卵巢交界性肿瘤复发以及评估剩余正常功能实质的数量方面起着关键作用。迄今为止,尚无关于卵巢交界性肿瘤复发自然史的数据。
本研究的目的是通过超声检查定期随访,确定既往因卵巢交界性肿瘤接受保留生育功能手术的女性复发性卵巢囊肿的生长速度。
在这项前瞻性观察性研究中,我们收集了34例既往因卵巢交界性肿瘤接受保留生育功能手术且有可疑复发病变的患者的数据。患者每3个月接受一次经阴道超声检查,直至临床情况建议进行手术。根据研究开始时囊肿的大小,将患者分为3组:≤10毫米、10 - 20毫米和>20毫米。还获得了囊肿大小、生长速度以及随访期间首次超声检查时囊肿大小保持在同一维度类别的概率的汇总统计数据。对于每个囊肿,生长速度计算为两次连续测量之间线性插值的斜率。
在单因素和多因素分析中,随访时间(P <.001)、囊肿大小(P <.001)和微乳头模式(P <.001)均是显著影响囊肿生长的因素。根据首次超声检查时的大小类别,生长速度范围从<10毫米的囊肿最低0.06毫米/月到>20毫米的囊肿最高1.92毫米/月。所有复发病变的最终组织学检查证实与原发性卵巢交界性肿瘤的组织学类型相同。
本文是第一项观察性研究,描述了卵巢交界性肿瘤复发的生长速度与首次超声检查时检测到的大小之间的关系趋势。本研究结果似乎证实,在选定的患者中,对卵巢交界性肿瘤复发进行全面的超声随访已被证明是安全可行的。这种管理的最终目标是在不恶化这些年轻女性预后的情况下,最大限度地提高对其生育潜力的影响。